Momenta Pharmaceuticals, Inc. financial reports, Momenta Pharmaceuticals, Inc. annual revenue in 2024. When does Momenta Pharmaceuticals, Inc. report revenue?
Momenta Pharmaceuticals, Inc. total revenue, net income and dynamics of changes in US dollar today
Momenta Pharmaceuticals, Inc. net revenue for today is 6 391 000 $. The dynamics of Momenta Pharmaceuticals, Inc. net revenue increased by 1 209 000 $ from the last reporting period. The dynamics of net income of Momenta Pharmaceuticals, Inc. has changed by 69 426 000 $ in recent years. The financial graph of Momenta Pharmaceuticals, Inc. shows the values and changes of such indicators: total assets, net income, net revenue. The value of "net income" Momenta Pharmaceuticals, Inc. on the graph is displayed in blue. All information on Momenta Pharmaceuticals, Inc. total revenue on this chart is created in the form of yellow bars.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
30/09/2019
6 391 000 $
-57.0613 % ↓
-44 543 000 $
-
30/06/2019
5 182 000 $
-60.233 % ↓
-113 969 000 $
-
31/03/2019
4 113 000 $
-15.231 % ↓
-44 843 000 $
-
31/12/2018
42 822 000 $
-33.72 % ↓
-8 245 000 $
-159.924 % ↓
30/09/2018
14 884 000 $
-
-50 300 000 $
-
30/06/2018
13 031 000 $
-
-69 885 000 $
-
31/03/2018
4 852 000 $
-
-47 631 000 $
-
31/12/2017
64 608 000 $
-
13 759 000 $
-
30/09/2017
24 090 000 $
-
-33 188 000 $
-
30/06/2017
23 570 000 $
-
-36 908 000 $
-
Show:
to
Momenta Pharmaceuticals, Inc. financial report charts
Dates of Momenta Pharmaceuticals, Inc. finance reports: 30/06/2017, 30/06/2019, 30/09/2019. The dates of the financial statements are determined by the accounting rules. The current date of the financial report of Momenta Pharmaceuticals, Inc. for today is 30/09/2019. Gross profit Momenta Pharmaceuticals, Inc. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Momenta Pharmaceuticals, Inc. is -28 267 000 $
Momenta Pharmaceuticals, Inc. quarterly report dates
Cost of revenue Momenta Pharmaceuticals, Inc. is the total cost of producing and distributing of products and services of a company. Cost of revenue Momenta Pharmaceuticals, Inc. is 34 658 000 $ Total revenue Momenta Pharmaceuticals, Inc. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Momenta Pharmaceuticals, Inc. is 6 391 000 $ Operating revenue Momenta Pharmaceuticals, Inc. is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides. Operating revenue Momenta Pharmaceuticals, Inc. is 6 391 000 $
Operating income Momenta Pharmaceuticals, Inc. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Momenta Pharmaceuticals, Inc. is -59 795 000 $ Net income Momenta Pharmaceuticals, Inc. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Momenta Pharmaceuticals, Inc. is -44 543 000 $ Current assets Momenta Pharmaceuticals, Inc. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Momenta Pharmaceuticals, Inc. is 286 144 000 $
30/09/2019
30/06/2019
31/03/2019
31/12/2018
30/09/2018
30/06/2018
31/03/2018
31/12/2017
30/09/2017
30/06/2017
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
-28 267 000 $
-15 365 000 $
-11 582 000 $
25 458 000 $
2 128 000 $
3 683 000 $
-
-
-
-
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
34 658 000 $
20 547 000 $
15 695 000 $
17 364 000 $
12 756 000 $
9 348 000 $
-
-
-
-
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
6 391 000 $
5 182 000 $
4 113 000 $
42 822 000 $
14 884 000 $
13 031 000 $
4 852 000 $
64 608 000 $
24 090 000 $
23 570 000 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
6 391 000 $
5 182 000 $
4 113 000 $
42 822 000 $
14 884 000 $
13 031 000 $
4 852 000 $
64 608 000 $
24 090 000 $
23 570 000 $
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
-59 795 000 $
-116 494 000 $
-48 065 000 $
-7 398 000 $
-36 280 000 $
-70 840 000 $
-49 002 000 $
12 633 000 $
-34 527 000 $
-38 065 000 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
-44 543 000 $
-113 969 000 $
-44 843 000 $
-8 245 000 $
-50 300 000 $
-69 885 000 $
-47 631 000 $
13 759 000 $
-33 188 000 $
-36 908 000 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
11 447 000 $
11 584 000 $
12 277 000 $
11 331 000 $
17 971 000 $
21 992 000 $
33 242 000 $
36 148 000 $
37 914 000 $
39 063 000 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
66 186 000 $
121 676 000 $
52 178 000 $
50 220 000 $
51 164 000 $
83 871 000 $
53 854 000 $
51 975 000 $
58 617 000 $
61 635 000 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
286 144 000 $
317 095 000 $
346 283 000 $
441 423 000 $
294 174 000 $
328 450 000 $
338 301 000 $
366 926 000 $
442 489 000 $
481 627 000 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
397 768 000 $
479 686 000 $
558 450 000 $
531 563 000 $
353 284 000 $
395 460 000 $
416 944 000 $
459 431 000 $
502 542 000 $
540 806 000 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
122 131 000 $
123 508 000 $
131 228 000 $
248 334 000 $
65 202 000 $
82 417 000 $
111 258 000 $
73 651 000 $
172 838 000 $
110 841 000 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
40 581 000 $
41 755 000 $
51 580 000 $
51 511 000 $
54 445 000 $
49 407 000 $
-
-
-
-
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
323 900 000 $
342 668 000 $
418 786 000 $
446 545 000 $
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
121 844 000 $
166 967 000 $
135 892 000 $
70 555 000 $
104 527 000 $
113 769 000 $
-
-
-
-
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
30.63 %
34.81 %
24.33 %
13.27 %
29.59 %
28.77 %
-
-
-
-
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
275 924 000 $
312 719 000 $
422 558 000 $
461 008 000 $
248 757 000 $
281 691 000 $
334 417 000 $
374 154 000 $
360 514 000 $
386 861 000 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-55 571 000 $
-73 670 000 $
-37 592 000 $
-34 198 000 $
-46 394 000 $
-36 845 000 $
-38 153 000 $
-38 209 000 $
-30 460 000 $
-24 731 000 $
Last revenue report of Momenta Pharmaceuticals, Inc. was 30/09/2019. According to last financial report total revenue in Momenta Pharmaceuticals, Inc. was 6 391 000 US dollar and changed by -57.0613% since last year. Net income in Momenta Pharmaceuticals, Inc. was -44 543 000 $ in last quartal, net income changes to -159.924%.
Total assets Momenta Pharmaceuticals, Inc. refers to the total amount of assets owned by a person or entity. Total assets Momenta Pharmaceuticals, Inc. is 397 768 000 $ Current cash Momenta Pharmaceuticals, Inc. - the sum of all of the cash a company has on the date of report. Current cash Momenta Pharmaceuticals, Inc. is 122 131 000 $ Current debt Momenta Pharmaceuticals, Inc. is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital. Current debt Momenta Pharmaceuticals, Inc. is 40 581 000 $
Momenta Pharmaceuticals, Inc. stocks data
MNTA stock price
Momenta Pharmaceuticals, Inc. stock price today, MNTA stock quote.
